DIVIDEND ANNOUNCEMENT: Abbott Laboratories (NYSE:ABT) on 02/20/2026 declared a dividend of $0.6300 per share

Abbott Laboratories (NYSE:ABT) on 02/20/2026 declared a dividend of $ 0.6300 per share payable on May 15, 2026 to shareholders of record as of April 15, 2026.

Abbott Laboratories (NYSE:ABT) has paid dividends since 1926, has a current dividend yield of 2.2461893559% and has increased its dividends for 12 successive years.

Abbott Laboratories's market cap is $ 195,084,049,680 and has a PE ratio of 14.08. The stock price closed yesterday at $ 112.19 and has a 52 week low/high of $ 105.27 and $ 141.23.

Abbott Laboratories is a global healthcare company involved in the discovery, development, manufacture, and sale of diverse healthcare products. It operates through four segments: Established Pharmaceutical Products, which focuses on international sales of branded generic pharmaceuticals; Diagnostic Products, which provides diagnostic systems and tests globally; Nutritional Products, offering a wide range of adult and pediatric nutrition products worldwide; and Medical Devices, which includes products for rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care.

For more information on Abbott Laboratories click here.